跳至主要内容
临床试验/NCT05300243
NCT05300243Unknown不适用

The Predictive Role of HPV Integration in HSIL and Cervical Cancer

Tongji Hospital1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2020年7月7日最近更新:
适应症

试验速览

阶段
不适用
入组人数
1
试验地点
1
主要终点
Tissue pathological diagnosis

研究概览

简要总结

The stratified analysis by the level of HPV DNA integration in HSIL and cervical cancer will be drawn to explore whether the status of HPV integration makes any difference in the progression of cervical cancer. The purpose of the research is to reduce the miss of cervix lesions and prove that HPV integration detection is sensitive in cervical cancer precise screening.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • HPV-positive patients; Patients have completed HPV detection, TCT, and HPV integration detection before surgery or biopsy; Patients with priced diagnoses accepted treatment according to ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors; Patients who are voluntary participants in this research and cooperate to follow-up with subscribing informed consent.

排除标准

  • Patients who are not suitable for the trial; Patients existing other subtype malignancy tumors are still in treatment.

结局指标

主要结局

Tissue pathological diagnosis

时间窗: 1year since HPV integrated test

Tissue pathological diagnosis in 1 year since HPV integrated test

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验